WallStreetZenWallStreetZen

NASDAQ: ANGO
Angiodynamics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ANGO stock forecasts and price targets.

Forecast return on equity

Is ANGO forecast to generate an efficient return?

Company
7.05%
Industry
24.45%
Market
178.05%
ANGO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANGO forecast to generate an efficient return on assets?

Company
4.69%
Industry
18.19%
ANGO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANGO earnings per share forecast

What is ANGO's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.30
Avg 2 year Forecast
-$0.11
Avg 3 year Forecast
$0.45

ANGO revenue forecast

What is ANGO's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$319.1M+1.73%
Avg 2 year Forecast
$334.9M+6.75%
Avg 3 year Forecast
$359.2M+14.5%
ANGO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ANGO revenue growth forecast

How is ANGO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
4.38%
Industry
10.68%
Market
13.79%
ANGO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANGO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANGO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
ANGO$10.31N/AN/A
EMBC$8.85$25.00+182.49%Strong Buy
AVR$5.50$15.50+181.82%Strong Buy
OSUR$3.08$3.00-2.60%Hold
UTMD$63.12N/AN/A
View Top Medical Stocks

Angiodynamics Stock Forecast FAQ

What is ANGO's earnings growth forecast for 2026-2028?

(NASDAQ: ANGO) Angiodynamics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 28.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.03%.

Angiodynamics's earnings in 2026 is -$31,387,000.On average, 6 Wall Street analysts forecast ANGO's earnings for 2026 to be -$12,222,135, with the lowest ANGO earnings forecast at -$13,362,537, and the highest ANGO earnings forecast at -$11,280,064. On average, 6 Wall Street analysts forecast ANGO's earnings for 2027 to be -$4,635,982, with the lowest ANGO earnings forecast at -$5,264,030, and the highest ANGO earnings forecast at -$3,470,789.

In 2028, ANGO is forecast to generate $18,543,929 in earnings, with the lowest earnings forecast at $17,816,716 and the highest earnings forecast at $19,089,339.

If you're new to stock investing, here's how to buy Angiodynamics stock.

What is ANGO's revenue growth forecast for 2026-2028?

(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of 4.38% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.

Angiodynamics's revenue in 2026 is $313,725,000.On average, 6 Wall Street analysts forecast ANGO's revenue for 2026 to be $13,186,518,533, with the lowest ANGO revenue forecast at $12,633,671,450, and the highest ANGO revenue forecast at $13,607,558,277. On average, 6 Wall Street analysts forecast ANGO's revenue for 2027 to be $13,837,704,634, with the lowest ANGO revenue forecast at $13,200,566,964, and the highest ANGO revenue forecast at $14,317,004,048.

In 2028, ANGO is forecast to generate $14,842,167,457 in revenue, with the lowest revenue forecast at $14,259,983,945 and the highest revenue forecast at $15,278,908,389.

What is ANGO's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ANGO) forecast ROA is 4.69%, which is lower than the forecast US Medical Instruments & Supplies industry average of 18.19%.

What is ANGO's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ANGO) Angiodynamics's current Earnings Per Share (EPS) is -$0.75. On average, analysts forecast that ANGO's EPS will be -$0.30 for 2026, with the lowest EPS forecast at -$0.32, and the highest EPS forecast at -$0.27. On average, analysts forecast that ANGO's EPS will be -$0.11 for 2027, with the lowest EPS forecast at -$0.13, and the highest EPS forecast at -$0.08. In 2028, ANGO's EPS is forecast to hit $0.45 (min: $0.43, max: $0.46).

What is ANGO's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ANGO) forecast ROE is 7.05%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.